Jonathan Chee

13PUBLICATIONS
52CO-AUTHORS
Tumour immunologyNanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 10, 2026
Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8+ T cells in lymph nodes.

Junyun Lai, Cheok Weng Chan, Jesse D Armitage

|Dec 12, 2024
Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma.

Jourdin R C Rouaen, Antonietta Salerno, Tyler Shai-Hee

|Sep 29, 2024
Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade.

Nicola Principe, Amber-Lee Phung, Kofi L P Stevens

|Apr 30, 2024
Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes.

Joel Kidman, Rachael M Zemek, John-William Sidhom

|Nov 03, 2022
Diabetes induced by checkpoint inhibition in nonobese diabetic mice can be prevented or reversed by a JAK1/JAK2 inhibitor.

Tingting Ge, Amber-Lee Phung, Gaurang Jhala

|Jul 21, 2021
Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies.

Shamin Li, Yannick Simoni, Summer Zhuang

Pageof 3

Frequent Collaborators

3 joint publications

Ian M Dick

2 joint publications

Vanessa S Fear

2 joint publications

Scott A Fisher

2 joint publications

Nicola Principe